Medtronic PLC (MDT)
81.29
+0.72
(+0.89%)
USD |
NYSE |
Apr 23, 16:00
81.50
+0.21
(+0.26%)
After-Hours: 20:00
Medtronic Revenue (Quarterly): 8.089B for Jan. 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 8.089B |
| October 31, 2023 | 7.984B |
| July 31, 2023 | 7.702B |
| April 30, 2023 | 8.545B |
| January 31, 2023 | 7.727B |
| October 31, 2022 | 7.585B |
| July 31, 2022 | 7.371B |
| April 30, 2022 | 8.089B |
| January 31, 2022 | 7.763B |
| October 31, 2021 | 7.847B |
| July 31, 2021 | 7.987B |
| April 30, 2021 | 8.188B |
| January 31, 2021 | 7.775B |
| October 31, 2020 | 7.647B |
| July 31, 2020 | 6.507B |
| April 30, 2020 | 5.997B |
| January 31, 2020 | 7.717B |
| October 31, 2019 | 7.706B |
| July 31, 2019 | 7.493B |
| April 30, 2019 | 8.146B |
| January 31, 2019 | 7.546B |
| October 31, 2018 | 7.481B |
| July 31, 2018 | 7.384B |
| April 30, 2018 | 8.144B |
| January 31, 2018 | 7.369B |
| Date | Value |
|---|---|
| October 31, 2017 | 7.05B |
| July 31, 2017 | 7.39B |
| April 30, 2017 | 7.916B |
| January 31, 2017 | 7.283B |
| October 31, 2016 | 7.345B |
| July 31, 2016 | 7.166B |
| April 30, 2016 | 7.567B |
| January 31, 2016 | 6.934B |
| October 31, 2015 | 7.058B |
| July 31, 2015 | 7.274B |
| April 30, 2015 | 7.304B |
| January 31, 2015 | 4.318B |
| October 31, 2014 | 4.366B |
| July 31, 2014 | 4.273B |
| April 30, 2014 | 4.565B |
| January 31, 2014 | 4.163B |
| October 31, 2013 | 4.194B |
| July 31, 2013 | 4.083B |
| April 30, 2013 | 4.46B |
| January 31, 2013 | 4.027B |
| October 31, 2012 | 4.095B |
| July 31, 2012 | 4.008B |
| April 30, 2012 | 4.297B |
| January 31, 2012 | 3.918B |
| October 31, 2011 | 4.023B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
5.997B
Minimum
Apr 2020
8.545B
Maximum
Apr 2023
7.693B
Average
7.745B
Median
Revenue (Quarterly) Benchmarks
| Abbott Laboratories | 9.964B |
| Boston Scientific Corp | 3.725B |
| Stryker Corp | 5.815B |
| Axonics Inc | 109.74M |
| Conmed Corp | 327.04M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.322B |
| Total Expenses (Quarterly) | 6.586B |
| EPS Diluted (Quarterly) | 0.99 |
| Enterprise Value | 123.99B |
| Gross Profit Margin (Quarterly) | 65.61% |
| Profit Margin (Quarterly) | 16.34% |
| Earnings Yield | 3.86% |
| Operating Earnings Yield | 5.67% |
| Normalized Earnings Yield | 4.191 |